,Drug_name,Brand_name,DrugId,Brand_name,Sponsor,Properties,Indication,Indication_EFO,DiseaseId,TA,Year
1,Glucarpidase ,Voraxaze,,,,Recombinant bacterial enzyme that hydrolyses methotrexate,Toxic plasma methotrexate concentrations in patients with delayed methotrexate clearance,,,,2012
2,Ingenol mebutate ,Picato,,,,MOA unknown,Actinic keratosis,EFO_0002496,actinic keratosis,,2012
3,Axitinib ,Inlyta,,,,"VEGFR1, -2 and -3 inhibitor",Advanced renal cell carcinoma,,,,2012
4,Vismodegib ,Erivedge,,,,Smoothened (Hedgehog pathway) inhibitor,Metastatic or locally advanced basal cell carcinoma,,,,2012
5,Ivacaftor ,Kalydeco,,,,CFTR potentiator,Cystic fibrosis in patients with the G551D mutation in the CFTR gene,,,,2012
6,Tafluprost ,Zioptan,,,,Selective prostaglandin F prostanoid receptor agonist,Elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension,,,,2012
7,Lucinactant ,Surfaxin,,,,Pulmonary surfactant,Prevention of respiratory distress syndrome,,,,2012
8,Peginesatide acetate ,Omontys,,,,"Synthetic, pegylated erythropoiesis-stimulating agent",Anaemia due to chronic kidney disease,,,,2012
9,Florbetapir F-18 ,Amyvid,,,,Radioactive diagnostic agent,Diagnostic agent to estimate amyloid-β plaques in patients with suspected Alzheimer's disease,,,,2012
10,Avanafil ,Stendra,,,,PDE5 inhibitor,Erectile dysfunction,EFO_0004234,erectile dysfunction,,2012
11,Taliglucerase alfa ,Elelyso,,,,Recombinant β-glucocerebrosidase; produced in carrot cells,Gaucher's disease,MONDO_0018150,gaucher disease,,2012
12,Pertuzumab ,Perjeta,,,,HER2-targeting mAb,HER2-positive metastatic breast cancer,,,,2012
13,Lorcaserin ,Belviq,,,,5-HT2C receptor agonist,Obesity,EFO_0001073,obesity,,2012
14,Mirabegron ,Myrbetriq,,,,β3-adrenergic receptor agonist,Overactive bladder,EFO_1000781,overactive bladder,,2012
15,Citric acid; magnesium oxide; sodium picosulfate ,Prepopik,,,,Osmotic and stimulant laxatives,Cleansing of the colon before colonoscopy,,,,2012
16,Carfilzomib ,Kyprolis,,,,20S proteasome inhibitor,Multiple myeloma,EFO_0001378,multiple myeloma,,2012
17,Aclidinium bromide ,Tudorza Pressair,,,,Long-acting antimuscarinic agent,Bronchospasms associated with COPD,,,,2012
18,Ziv-aflibercept ,Zaltrap,,,,"Recombinant fusion protein that binds VEGFA, VEGFB and PIGF",Metastatic colorectal cancer,EFO_1001480,metastatic colorectal cancer,,2012
19,Cobicistat; elvitegravir; emtricitabine; tenofovir disoproxil fumarate ,Stribild,,,,Cytochrome P450 inhibitor; HIV-1 integrase inhibitor; NRTI; acyclic nucleoside phosphonate analogue,HIV-1 infection,EFO_0000180,hiv-1 infection,,2012
20,Tbo-Filgrastim ,Neutroval,,,,Methionyl human G-CSF,Severe neutropaenia in patients with non-myeloid malignancies,,,,2012
21,Linaclotide ,Linzess,,,,Guanylyl cyclase C agonist,Irritable bowel syndrome with constipation; chronic idiopathic constipation,,,,2012
22,Enzalutamide ,Xtandi,,,,Androgen receptor inhibitor,Metastatic castration-resistant prostate cancer,,,,2012
23,Bosutinib monohydrate ,Bosulif,,,,BCR–ABL inhibitor; SRC family kinase inhibitor,"Chronic, accelerated or blast phase Ph+ chronic myelogenous leukaemia",,,,2012
24,Teriflunomide ,Aubagio,,,,Dihydroorotate dehydrogenase inhibitor,Relapsing forms of multiple sclerosis,,,,2012
25,Choline C-11,,,,,Radiolabelled choline analogue,Diagnostic agent for imaging of patients with suspected prostate cancer recurrence,,,,2012
26,Regorafenib ,Stivarga,,,,"Multikinase inhibitor with targets including RET, VEGFR1, -2, -3 and KIT",Metastatic colorectal cancer,EFO_1001480,metastatic colorectal cancer,,2012
27,Ocriplasmin ,Jetrea,,,,Recombinant truncated form of human plasmin,Symptomatic vitreomacular adhesion,,,,2012
28,Perampanel ,Fycompa,,,,Non-competitive ionotropic AMPA glutamate receptor antagonist,Partial-onset seizures in patients with epilepsy,,,,2012
29,Omacetaxine mepesuccinate ,Synribo,,,,MOA unknown,Chronic or accelerated-phase chronic myeloid leukaemia,,,,2012
30,Tofacitinib ,Xeljanz,,,,JAK inhibitor,Severely active rheumatoid arthritis,,,,2012
31,Cabozantinib ,Cometriq,,,,"Multikinase inhibitor with targets including RET, MET, VEGFR1, -2, -3, KIT and FLT3","Progressive, metastatic medullary thyroid cancer",,,,2012
32,Ponatinib ,Iclusig,,,,"Multikinase inhibitor with targets including Bcr–Abl, KIT, RET and FLT3","Chronic, accelerated or blast-phase chronic myeloid leukaemia",,,,2012
33,Pasireotide diaspartate ,Signifor,,,,Somatostatin analogue,Cushing's disease,,,,2012
34,Raxibacumab,,,,,Human mAb against Bacillus anthracis toxin,Anthrax,EFO_0000778,anthrax infection,,2012
35,Teduglutide ,Gattex,,,,GLP2 analogue,Short bowel syndrome,MONDO_0015183,short bowel syndrome,,2012
36,Lomitapide ,Juxtapid,,,,Microsomal triglyceride transfer protein inhibitor,Homozygous familial hypercholesterolaemia,,,,2012
37,Apixaban ,Eliquis,,,,Factor Xa inhibitor,Stroke and systemic embolism in patients with non-valvular atrial fibrillation,,,,2012
38,Bedaquiline ,Sirturo,,,,Diarylquinoline antimycobacterial,Pulmonary multidrug-resistant tuberculosis,,,,2012
39,Crofelemer ,Fulyzaq,,,,CFTR and CaCC channel inhibitors,HIV-associated diarrhoea,,,,2012